| 1 |
Meng FH, Li YB, Xiong ZL, Jiang ZM, Li FM. Osteoblastic proliferative activity of Epimedium brevicornum Maxim. Phytomedicine. 2005;12:189-93.
DOI
ScienceOn
|
| 2 |
Yoshida H, Teramoto T, Ikeda K, Yamori Y. Glycitein effect on suppressing the proliferation and stimulating the differentiation of osteoblastic MC3T3-E1 cells. Biosci Biotechnol Biochem. 2001;65:1211-3.
DOI
ScienceOn
|
| 3 |
Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. High bone density due to a mutation in LDL-receptor-related protein-5. N Engl J Med. 2002;346:1513-21.
DOI
ScienceOn
|
| 4 |
Lo YC, Chang YH, Wei BL, Huang YL, Chiou WF. Betulinic acid stimulates the differentiation and mineralization of osteoblastic MC3T3-E1 cells: involvement of BMP/Runx2 and beta-catenin signals. J Agric Food Chem. 2010;58:6643-9.
DOI
ScienceOn
|
| 5 |
Husain SR, Cillard J, Cillard P. Hydroxyl radical scavenging activity of flavonoids. Phytochemistry. 1987;26;2489-92.
DOI
ScienceOn
|
| 6 |
Lee KH, Choi EM. Biochanin A stimulates osteoblastic differentiation and inhibits hydrogen peroxide-induced production of inflammatory mediators in MC3T3-E1 cells. Biol Pharm Bull. 2005;28:1948-53.
DOI
ScienceOn
|
| 7 |
Kostenuik PJ, Shalhoub V. Osteoprotegerin: A physiological and pharmacological inhibitor of bone resorption. Curr Pharm Des. 2001;7:613-35.
DOI
ScienceOn
|
| 8 |
Lane NE, Kelman A. A review of anabolic therapies for osteoporosis. Arthritis Res Ther. 2003;5:214-22.
DOI
ScienceOn
|
| 9 |
Liu HC, Chen RM, Jian WC, Lin YL. Cytotoxic and antioxidant effects of the water extract of the traditional Chinese herb gusuibu (Drynaria fortunei) on rat osteoblasts. J Formos Med Assoc. 2001;100:383-8.
|
| 10 |
Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332:305-11.
DOI
ScienceOn
|
| 11 |
Martin JH, Matthews JL. Mitochondrial granules in chondrocytes, osteoblasts and osteocytes. An ultrastructural and microincineration study. Clin Orthop. 1970;68:273-8.
|
| 12 |
Morris C, Thorpe J, Ambrosio L, Santin M. The soybean isoflavone genistein induces differentiation of MG63 human osteosarcoma osteoblasts. J Nutr. 2006;136:1166-70.
DOI
|
| 13 |
Notoya M, Tsukamoto Y, Nishimura H, Woo JT, Nagai K, Lee IS, Hagiwara H. Quercetin, a flavonoid, inhibits the proliferation, differentiation, and mineralization of osteoblasts in vitro. Eur J Pharmacol. 2004;485:89-96.
DOI
ScienceOn
|
| 14 |
Owen ME. Lineage of osteogenic cells and their relationship to the stromal system. in Bone and Mineral Research, edited by Peck WA, pp 1-25, Elsevier Science Publisher, Amsterdam, 1985.
|
| 15 |
Choi EM. Modulatory effects of luteolin on osteoblastic function and inflammatory mediators in osteoblastic MC3T3- E1 cells. Cell Biology International 2007b;31:870-7.
DOI
ScienceOn
|
| 16 |
Formica JV, Regelson W. Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol. 1995; 33:1061-80.
DOI
ScienceOn
|
| 17 |
Ducy P, Schinke T, Karsenty G. The osteoblast: A sophisticated fibroblast under central surveillance. Science. 2000; 289:1501-4.
DOI
ScienceOn
|
| 18 |
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/ Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747-54.
DOI
ScienceOn
|
| 19 |
Fauran-Clavel MJ, Oustrin J. Alkaline phosphatase and bone calcium parameters. Bone. 1986;7:95-9.
DOI
ScienceOn
|
| 20 |
Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 1997;57:2916-21.
|
| 21 |
Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, Suda T, Yamaguchi A. Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF). Biochem Biophys Res Commun. 1998;252:697-702.
DOI
ScienceOn
|
| 22 |
Han LM, Liu B, Xu P. Influence of Herba epimedii flavones on proliferation of osteoblast. Shanghai J tradit Chinese Med. 2003;37:56-8.
|
| 23 |
Hidaka S, Okamoto Y, Nakajima K. Preventive effects of traditional Chinese medicines on experimental osteoporosis induced by ovariectomy in rats. Caicif Tissue Int. 1997; 61:239-46.
DOI
ScienceOn
|
| 24 |
Hsu YL, Chang JK, Tsai CH, Chien TT, Kuo PL. Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. Biochem Pharmacol. 2007;73:504-14.
DOI
ScienceOn
|
| 25 |
Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins Growth Factors. 2004;22:233-41.
DOI
ScienceOn
|
| 26 |
Avila MA, Velasco JA, Cansado J, Notario V. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res. 1994; 54:2424-8.
|
| 27 |
Bellows CG, Aubin JE, Heersche JNM. Initiation and progression of mineralization of bone nodules formed in vitro - the role of alkaline phosphatase and organic phosphate. Bone and Mineral 1991;14:27-40.
DOI
ScienceOn
|
| 28 |
Berg C, Neumeyer K, Kirkpatrick P. Teriparatide. Nat Rev Drug Discov. 2003;2:257-8.
DOI
|
| 29 |
Choi EM. Apigenin increases osteoblastic differentiation and inhibits tumor necrosis factor-alpha-induced production of interleukin-6 and nitric oxide in osteoblastic MC3T3-E1 cells. Pharmazie 2007a;62:216-20.
|
| 30 |
Zhang Y, Zeng X, Zhang L, Zheng X. Stimulatory effects of puerarin on bone formation through activation of PI3K/Akt pathway in rat calvaria osteoblasts. Planta Med. 2007; 73:341-7.
DOI
ScienceOn
|
| 31 |
Wang X, Goh CH, Li B. p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix. Endocrinology. 2007;148:1629-37.
DOI
|
| 32 |
Prouillet C, Mazière JC, Mazière C, Wattel A, Brazier M, Kamel S. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol. 2004;67:1307-13.
DOI
ScienceOn
|
| 33 |
Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000;289:1508-14.
DOI
|
| 34 |
Stein GS, Lian JB. Molecular mechanisms mediating proliferation/ differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev. 1993;14:424-42.
DOI
|
| 35 |
Sugimoto E, Yamaguchi M. Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int J Mol Med. 2000;5:515-20.
|
| 36 |
Suzuki H, Hayakawa M, Kobayashi K, Takiguchi H, Abiko Y. H2O2-derived free radicals treated fibronectin substratum reduces the bone nodule formation of rat calvarial osteoblast. Mech Ageing Dev. 1997;98:113-25.
DOI
ScienceOn
|
| 37 |
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242:1528-34.
DOI
|
| 38 |
Xie F, Wu CF, Lai WP, Yang XJ, Cheung PY, Yao XS, Leung PC, Wong MS. The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro. eCAM. 2005;2:353-61.
|
| 39 |
Yin XX, Chen ZQ, Liu ZJ, Ma QJ, Dang GT. Icariine stimulates proliferation and differentiation of human osteoblasts by increasing production of bone morphogenetic protein-2. Chin Med J (Engl). 2007;120:204-10.
|
| 40 |
Zhang DW, Cheng Y, Wang NL, Zhang JC, Yang MS, Yao XS. Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts. Phytomedicine. 2008; 15:55-61.
DOI
ScienceOn
|
| 41 |
Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755-64.
DOI
ScienceOn
|
webmaster
